News

Skyphos to Showcase Additive Lithography at the Microfluidics Consortium Open Day in Boston

Skyphos Technologies, a Virginia Tech Corporate Research Center company advancing micro-scale and additive lithography manufacturing, will participate in the Microfluidics Consortium Open Day Meeting in Boston, where the company has been invited to present in the Physical Microfluidics Hotseat and deliver a tabletop demonstration.

The Microfluidics Consortium convenes worldwide leaders, from research and industry, bringing together stakeholders from materials, device development, instrumentation, and applications to accelerate adoption of microfluidics-enabled products and services. The Boston meeting is part of the consortium’s international event series and is organized around expert talks, startup hot-seat pitches, live demonstrations, and face-to-face networking.

At the event, Skyphos will highlight its advanced micro-fabrication platform and vertically integrated approach, aimed at enabling scalable, high-precision production of microdevice architectures outside of the clean room at scale. Skyphos specializes in components and process development relevant to lab-on-a-chip systems and related applications.

Participation in the Physical Microfluidics Hot-Seat places Skyphos alongside emerging companies and thought leaders presenting new approaches in the fields of diagnostics, therapeutics, organ-on-chip, synthetic biology, and next-generation microfluidic systems. The consortium’s broader mission is to connect participants from across Europe, the United States, and Asia to help move promising microfluidics technologies from concept toward commercial use.

“Skyphos is building manufacturing infrastructure for the next generation of microfluidic devices,” said Elliot McAllister- Founder. “This invitation to Boston reflects a growing recognition that scalable microfabrication remains a key bottleneck to the field. Skyphos and others are showing that new manufacturing models can translate and grow strong techniques and applications. Getting cures from lab to fab.”

Located within the Virginia Tech Corporate Research Center community, Skyphos represents the kind of deep-tech company the CRC was built to support: a venture combining advanced engineering, research-driven innovation, and commercial ambition. The company’s participation in Boston underscores the reach of Virginia-based innovation in emerging sectors where manufacturing and life sciences intersect.

 

Recent News

08/10/2026

Expanding visibility with wearable blood pressure monitoring: CareTaker

In higher-risk patient populations, across all points of care, a patient’s condition can deteriorate quickly between routine vital sign checks, creating critical gaps in visibility and leaving clinical deterioration undetected between rounds. Continuous clinical-grade non-invasive blood pressure (CNIBP) monitoring, combined with hemodynamic trending, helps close these gaps by providing a more complete view of patient

08/10/2026

BIO-CAT Joins the Lallemand Family

BIO-CAT is pleased to join the Lallemand family as we begin an exciting new chapter together. Effective July 31, 2026, Lallemand Inc. has completed its acquisition of BIO-CAT Enzymes & Microbials. Together, we are combining complementary expertise in enzymes, microbial technologies, fermentation, and life science innovation to create an even stronger platform for developing next-generation

08/05/2026

Virginia Catalyst Announces Opening of Grant Round 20

The Virginia Catalyst announced that it is accepting letters of intent (LOI) for Grant Round 20 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “The Virginia Catalyst is excited to open Grant Round 20 to continue our support of Virginia’s